Mobile intracardiac calcinosis: A new risk of thromboembolism in patients with haemodialysed end stage renal disease

Heart

Volumn 82, Issue 5, 1999, Pages 638-640

  Tsuchihashi, K ^a   Nozawa, A ^b   Marusaki, S ^c   Moniwa, N ^a   Oh numa, Y ^a   Kuno, A ^a   Takagi, S ^a   Takizawa, H ^a   Ura, N ^a   Shimamoto, K ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Hokkaido Pref Hospital Kitami   (Japan)

^c Obihiro Kyoukai Hospital   (Japan)

Author keywords

Cardiac mass; End stage renal disease; Haemodialysis hypoparathyroidism; Intracardiac mobile calcinosis; Thromboembolism

Indexed keywords

ALFACALCIDOL; ANTIANGINA PECTORIS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CARBONATE; COLECALCIFEROL; GLYCEROL NITRATE;

AGED; ANEMIA; ANGINA PECTORIS; ARTICLE; CALCINOSIS; CARDIOGENIC SHOCK; CASE REPORT; CHRONIC GLOMERULONEPHRITIS; CHRONIC PYELONEPHRITIS; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIABETIC NEPHROPATHY; FEMALE; HEART MUSCLE ISCHEMIA; HEART TUMOR; HEMODIALYSIS; HUMAN; HYPOPARATHYROIDISM; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; KIDNEY TUBERCULOSIS; NEPHRECTOMY; NEPHRITIS; PRIORITY JOURNAL; THROMBOEMBOLISM;

EID: 0032742439     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.82.5.638     Document Type: Article

References (12)

1. 1 Dashkoff N, Karacuschansky M, Come PC, et al. Echocardiographic features of mitral annulus calcification. Am Heart J 1977;94:585-92.
2. 2 Nair CK, Aronow WS, Sketch NH, et al. Clinical and echocardiographic characteristics of patients with mitral annulus calcification. Am J Cardiol 1983;51:1992-0.
3. 3 Rostand SG, Sanders C, Kirk SG, et al. Myocardial calcification and cardiac dysfunctinn in chronic heart failure. Am J Med 1988;85:651-7.
4. 4 Kudoh Y, Iimura O. Study on the atherosclerosis mechanism in chronic haemodialysis. Jpn Circ J 1987;51:631-41.
5. 5 Nagao K, Tsuchihashi K, Ura N, et al. Appropriate hematocrit levels of erythropoietin supplemental therapy in end-staged renal failure complicated by coronary artery disease. Can J Cardiol 1997;13;747-53.
6. 6 Hampers CL, Katz AI, Wilson RE, et al. Calcium metabolism and osteodystrophy after renal transplantation. Arch Intern Med 1969;124:282-91.
7. 7 DePace NL, Rohrer AH, Kotler MN, et al. Rapidly progressing, massive mitral annular calcification. Occurrence in a patient with chronic renal failure. Arch Intern Med 1981;141:1663-70.
8. 8 Katz AI, Hampers CL, Merrill JP. Secondary hyperparathyroidism and renal osteodystrophy in chronic renal failure. Analysis of 195 patients, with observations of chronic dialysis, kidney transplantation, and subtotal parathyroidectomy. Medicine 1969;48:337-74.
9. 9 Fernandez E, Montoliu J. Successful treatment of massive uremic tumoral calcinosis with daily haemodialysis and very low calcium dialysate [letter]. Nephrol Dial Transplant 1994;9:1207-9.
10. 10 Ueyoshi A, Ota K. Clinical appraisal of vinpocetine for the removal of intractable tumoral calcinosis in haemodialysis patients with renal failure. J Int Med Res 1992;20:435-43.
11. 11 Akizawa T, Kinugasa E, Akiba T, et al. Incidence and clinical characteristics of hypoparathyroidism in dialysis patients. Kidney Int 1997;52:S72-4.
12. 12 Kurz P, Monier-Faugere MC, Bognar B, et al. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int 1994;46:855-61.